203 related articles for article (PubMed ID: 30273913)
1. A review on the abuse of three NPS (synthetic cannabinoids, kratom, poppers) among youths in Asia.
Bae K; Kwon NJ; Han E
Forensic Sci Int; 2018 Nov; 292():45-49. PubMed ID: 30273913
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of new psychoactive substances in Northeast Asia from 2007 to 2015.
Lee J; Yang S; Kang Y; Han E; Feng LY; Li JH; Chung H
Forensic Sci Int; 2017 Mar; 272():1-9. PubMed ID: 28088088
[TBL] [Abstract][Full Text] [Related]
3. [Kiken drugs: current status of abuse among youth in the nightlife areas of Tokyo].
Shimane T
Nihon Rinsho; 2015 Sep; 73(9):1491-6. PubMed ID: 26394509
[TBL] [Abstract][Full Text] [Related]
4. Motivations for new psychoactive substance use among regular psychostimulant users in Australia.
Sutherland R; Bruno R; Peacock A; Lenton S; Matthews A; Salom C; Dietze P; Butler K; Burns L; Barratt MJ
Int J Drug Policy; 2017 May; 43():23-32. PubMed ID: 28161577
[TBL] [Abstract][Full Text] [Related]
5. Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis.
Kassai S; Pintér JN; Rácz J; Böröndi B; Tóth-Karikó T; Kerekes K; Gyarmathy VA
Harm Reduct J; 2017 Feb; 14(1):9. PubMed ID: 28187774
[TBL] [Abstract][Full Text] [Related]
6. "Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances.
Zawilska JB
Int Rev Neurobiol; 2015; 120():273-300. PubMed ID: 26070762
[TBL] [Abstract][Full Text] [Related]
7. New and Emerging Illicit Psychoactive Substances.
Graddy R; Buresh ME; Rastegar DA
Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
[TBL] [Abstract][Full Text] [Related]
8. Severe illness associated with reported use of synthetic cannabinoids: a public health investigation (Mississippi, 2015).
Kasper AM; Ridpath AD; Gerona RR; Cox R; Galli R; Kyle PB; Parker C; Arnold JK; Chatham-Stephens K; Morrison MA; Olayinka O; Preacely N; Kieszak SM; Martin C; Schier JG; Wolkin A; Byers P; Dobbs T
Clin Toxicol (Phila); 2019 Jan; 57(1):10-18. PubMed ID: 29989463
[TBL] [Abstract][Full Text] [Related]
9. Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature.
Singh D; Narayanan S; Vicknasingam B
Brain Res Bull; 2016 Sep; 126(Pt 1):41-46. PubMed ID: 27178014
[TBL] [Abstract][Full Text] [Related]
10. [Bonzai, lead and bath salt-poisoning with new and old drugs : Synthetic amphetamines, cathinones, cannabinoids and opioids-an overview].
Strube J; Schaper A
Med Klin Intensivmed Notfmed; 2019 Nov; 114(8):684-692. PubMed ID: 29404633
[TBL] [Abstract][Full Text] [Related]
11. Do You Get What You Paid For? An Examination of Products Advertised as Kratom.
Griffin OH; Daniels JA; Gardner EA
J Psychoactive Drugs; 2016; 48(5):330-335. PubMed ID: 27669103
[TBL] [Abstract][Full Text] [Related]
12. New psychoactive substance use among regular psychostimulant users in Australia, 2010-2015.
Sutherland R; Peacock A; Whittaker E; Roxburgh A; Lenton S; Matthews A; Butler K; Nelson M; Burns L; Bruno R
Drug Alcohol Depend; 2016 Apr; 161():110-8. PubMed ID: 26880592
[TBL] [Abstract][Full Text] [Related]
13. New psychoactive substances in Turkey: Narcotics cases assessed by the Council of Forensic Medicine between 2016 and 2017 in Ankara, Turkey.
Göl E; Çok I
Forensic Sci Int; 2019 Jan; 294():113-123. PubMed ID: 30502695
[TBL] [Abstract][Full Text] [Related]
14. Psychosis and synthetic cannabinoids.
Deng H; Verrico CD; Kosten TR; Nielsen DA
Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871
[TBL] [Abstract][Full Text] [Related]
15. Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies.
Assi S; Gulyamova N; Ibrahim K; Kneller P; Osselton D
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631432
[TBL] [Abstract][Full Text] [Related]
16. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.
Warner ML; Kaufman NC; Grundmann O
Int J Legal Med; 2016 Jan; 130(1):127-38. PubMed ID: 26511390
[TBL] [Abstract][Full Text] [Related]
17. Top 10 Facts You Need to Know About Synthetic Cannabinoids: Not So Nice Spice.
Kemp AM; Clark MS; Dobbs T; Galli R; Sherman J; Cox R
Am J Med; 2016 Mar; 129(3):240-4.e1. PubMed ID: 26522795
[TBL] [Abstract][Full Text] [Related]
18. Typology of new psychoactive substance use among the general Australian population.
Sutherland R; Peacock A; Roxburgh A; Barratt MJ; Burns L; Bruno R
Drug Alcohol Depend; 2018 Jul; 188():126-134. PubMed ID: 29775956
[TBL] [Abstract][Full Text] [Related]
19. Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis.
Mensen VT; Vreeker A; Nordgren J; Atkinson A; de la Torre R; Farré M; Ramaekers JG; Brunt TM
Psychopharmacology (Berl); 2019 Sep; 236(9):2677-2685. PubMed ID: 30968175
[TBL] [Abstract][Full Text] [Related]
20. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
Palamar JJ; Martins SS; Su MK; Ompad DC
Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]